Create a narrative

Tarsus Pharmaceuticals Community

NasdaqGS:TARS Community

1 Narratives written by author
0 Comments on narratives written by author
12 Fair Values set on narratives written by author

Create a narrative

Tarsus Pharmaceuticals

AN

AnalystConsensusTarget

Consensus Narrative from 8 Analysts

Expanding Ocular And Parasitic Markets Will Drive Future Value

Key Takeaways Strong growth driven by expanding XDEMVY adoption, a broader addressable market, favorable demographics, and new indications and geographies diversifying revenue streams. High margins and supportive capital position enable continued investment, while industry trends and regulatory receptivity enhance prospects for valuations and strategic partnerships.

US$73.50

FV

40.3% undervalued

49.67%

Revenue growth p.a.

0

0

12

6 days ago